Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Arrhythmia risk in left ventricular hypertrophy].

C Perings1, M Hennersdorf, E G Vester

  • 1Heinrich-Heine-Universität Düsseldorf, Medizinische Klinik und Poliklinik B, Klinik für Kardiologie, Pneumologie und Angiologie.

Zeitschrift Fur Kardiologie
|May 16, 2000
PubMed
Summary

Patients with arterial hypertension have a high incidence of arrhythmias. Left ventricular hypertrophy (LVH) is a key predictor of ventricular arrhythmias, and its regression may decrease their prevalence.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Determinants of long-term follow-up after stent implantation in acute myocardial infarction].

Zeitschrift fur Kardiologie·2002
Same author

[Autonomic dysfunction in cardiopulmonary diseases].

Der Internist·2002
Same author

[Autonomic dysfunction in heart diseases and diabetes mellitus. Monitoring and diagnosis].

Der Internist·2002
Same author

Successful thrombolysis of st. Jude medical aortic prosthesis with tissue-type plasminogen activator in a pregnant woman: a case report.

Cardiology in review·2002
Same author

Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy.

Cardiology·2002
Same author

[Cardiological diagnosis in patients with obstructive sleep apnea].

Deutsche medizinische Wochenschrift (1946)·2002

Area of Science:

  • Cardiology
  • Internal Medicine
  • Clinical Electrophysiology

Background:

  • Arterial hypertension significantly increases the risk of supraventricular and ventricular arrhythmias compared to normotensive individuals.
  • Left ventricular hypertrophy (LVH) is a critical predictor of ventricular arrhythmogenic risk.
  • Impaired left ventricular function, enlarged ventricular volumes, and the presence of late potentials are associated with increased arrhythmia risk in hypertensive patients.

Purpose of the Study:

  • To investigate the relationship between left ventricular hypertrophy (LVH) and ventricular arrhythmias in patients with arterial hypertension.
  • To explore the potential of pharmacological regression of LVH in reducing the prevalence of complex arrhythmias.

Main Methods:

  • Analysis of arrhythmia incidence in hypertensive versus normotensive patients.

Related Experiment Videos

  • Identification of predictors for ventricular arrhythmogenic risk, including LVH, impaired left ventricular function, and late potentials.
  • Correlation of hypertension duration, muscle mass index, and documented arrhythmias (couplets, non-sustained ventricular tachycardias) with life-threatening arrhythmias.
  • Electrophysiological studies to assess ventricular vulnerability in relation to LVH.
  • Observation of the effect of LVH regression on ventricular extrasystole rates.

    • Main Results:

    • Hypertensive patients exhibit a significantly higher incidence of arrhythmias (up to 96%) compared to normotensives.
    • LVH, impaired left ventricular function, and late potentials are significant predictors of ventricular arrhythmias.
    • Specific criteria like Simson criteria (fQRS, RMS) appear to identify patients at risk.
    • Longer hypertension duration, higher muscle mass index, and frequent ventricular ectopy correlate with life-threatening arrhythmias.
    • Ventricular vulnerability in electrophysiological studies is strongly dependent on LVH, and LVH regression is associated with reduced ventricular extrasystoles.

    Conclusions:

    • Left ventricular hypertrophy is a major determinant of ventricular arrhythmias in arterial hypertension.
    • Pharmacological regression of LVH is hypothesized to decrease the prevalence of complex arrhythmias.
    • Targeting LVH may be a therapeutic strategy to mitigate arrhythmia risk in hypertensive patients.